Investigating Big Pharma Licensing Trends

AstraZeneca’s Licensing Tactics Make It Top Dealmaker

 
• By Andrew McConaghie
  
Graph_Arrows
In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

SpotifyApple PodcastsWebsite

More from Deal-Making

More from In Vivo